Agah Ramtin
SEC insider (Form 3/4/5 filer). CIK 0001862617. Chief Medical Officer at RenovoRx, Inc. (RNXT). 16 reported Form 4/5 transactions since Sep 2024; latest on Apr 3, 2026. Located in MOUNTAIN VIEW, CA.
Companies Agah Ramtin has filed insider reports for
- RenovoRx, Inc. (RNXT): Director, Officer, Chief Medical Officer
Agah Ramtin
CIK: 0001862617
Transaction Breakdown
Open Market Buys (P)12 (75.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (18.8%)
Compensation grants
Other (G, F, J, C, D, …)1 (6.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNXT
RenovoRx, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Apr 3, 2026RNXT
RenovoRx, Inc.
AwardDirectStock Option
621.7K shares- - Jan 21, 2026RNXT
RenovoRx, Inc.
PurchaseDirect10K shares at avg. $1.00$10K - Dec 31, 2025RNXT
RenovoRx, Inc.
PurchaseDirect9.8K shares at avg. $0.86$8K - Dec 30, 2025RNXT
RenovoRx, Inc.
PurchaseDirect205 shares at avg. $0.83$169.33 - Dec 16, 2025RNXT
RenovoRx, Inc.
PurchaseDirect12K shares at avg. $0.85$10K - Dec 5, 2025RNXT
RenovoRx, Inc.
PurchaseDirect10K shares at avg. $0.96$10K - Nov 24, 2025RNXT
RenovoRx, Inc.
PurchaseDirect12K shares at avg. $0.80$10K - Nov 21, 2025RNXT
RenovoRx, Inc.
PurchaseDirect10K shares at avg. $0.80$8K - Jul 1, 2025RNXT
RenovoRx, Inc.
AwardDirectStock Option
63.6K shares- - Jun 5, 2025RNXT
RenovoRx, Inc.
PurchaseDirect21K shares at avg. $1.40$29K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 3, 2026 | RNXT RenovoRx, Inc. | Award Stock Option | 621,727 | - | - | Direct |
| Jan 21, 2026 | RNXT RenovoRx, Inc. | Purchase | 10,000 | $1.00 | $9,975 | Direct |
| Dec 31, 2025 | RNXT RenovoRx, Inc. | Purchase | 9,795 | $0.86 | $8,424 | Direct |
| Dec 30, 2025 | RNXT RenovoRx, Inc. | Purchase | 205 | $0.83 | $169 | Direct |
| Dec 16, 2025 | RNXT RenovoRx, Inc. | Purchase | 12,000 | $0.85 | $10,200 | Direct |
| Dec 5, 2025 | RNXT RenovoRx, Inc. | Purchase | 10,000 | $0.96 | $9,600 | Direct |
| Nov 24, 2025 | RNXT RenovoRx, Inc. | Purchase | 12,000 | $0.80 | $9,600 | Direct |
| Nov 21, 2025 | RNXT RenovoRx, Inc. | Purchase | 10,000 | $0.80 | $8,000 | Direct |
| Jul 1, 2025 | RNXT RenovoRx, Inc. | Award Stock Option | 63,636 | - | - | Direct |
| Jun 5, 2025 | RNXT RenovoRx, Inc. | Purchase | 21,000 | $1.40 | $29,400 | Direct |
1-10 of 16 transactions